Apolipoprotein A-IV attenuates oxidant-induced apoptosis in mitotic competent, undifferentiated cells by modulating intracellular glutathione redox balance

American Journal of Physiology - Cell Physiology

Volumn 290, Issue 1, 2006, Pages

  Spaulding, Heather L ^a   Saijo, Fumito ^a   Turnage, Richard H ^a   Alexander, J Steven ^b   Tak, Yee Aw ^b   Kalogeris, Theodore J ^a,b  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Antisense; Dehydroisoandrosterone; Diamide; Glucose 6 phosphate dehydrogenase; tert butyl hydroperoxide

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; APOLIPOPROTEIN A4; DIAMIDE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; PRASTERONE; RECOMBINANT APOLIPOPROTEIN A4; RECOMBINANT PROTEIN; TERT BUTYL HYDROPEROXIDE; UNCLASSIFIED DRUG; APOLIPOPROTEIN A; APOLIPOPROTEIN A-IV; APOLIPOPROTEIN A1; OXIDIZING AGENT;

APOPTOSIS; ARTICLE; CELL STRAIN; CONTROLLED STUDY; DRUG EFFECT; HUMAN; MITOSIS; PRIORITY JOURNAL; ANIMAL; CELL DIFFERENTIATION; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHYSIOLOGY; RAT;

ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS A; APOPTOSIS; CELL DIFFERENTIATION; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HUMANS; MITOSIS; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PC12 CELLS; RATS; RECOMBINANT PROTEINS; TERT-BUTYLHYDROPEROXIDE;

EID: 33644829838     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00388.2005     Document Type: Article

References (35)

1. Apfelbaum TF, Davidson NO, and Glickman RM. Apolipoprotein A-IV synthesis in rat intestine: regulation by dietary triglyceride. Am J Physiol Gastrointest Liver Physiol 252: G662-G666, 1987.
2. Aw TY. Molecular and cellular responses to oxidative stress and changes in oxidation-reduction imbalance in the intestine. Am J Clin Nutr 70: 557-565, 1999.
3. Aw TY and Pias EK. Mechanisms of parenchymal apoptosis. In: Molecular Basis for Microcirculatory Disorders, edited by Schmid-Schonbein GW and Granger DN. Paris, France: Springer-Verlag, 2003.
4. Aw TY and Rhoads CA. Glucose regulation of hydroperoxide metabolism in rat intestine cells: stimulation of reduced nicotinamide adenine dinucleotide phosphate supply. J Clin Invest 94: 2426-2434, 1994.
5. Chandra J, Samali A, and Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 29: 323-333, 2000.
6. Cohen RD, Castellani LW, Qiao JH, Van Lenten BJ, Lusis AJ, and Reue K. Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV. J Clin Invest 99: 1906-1916, 1997.
7. Deutsch J. Glucose-6-phosphate dehydrogenase. Methods Enzymol Anal 3: 190-196, 1983.
8. Duverger N, Murry-Brelier A, Latta M, Reboul S, Castro G, Mayaux JF, Fruchart JC, Taylor JM, Steinmetz A, and Denèfle P. Functional characterization of human recombinant apolipoprotein AIV produced in Escherichia coli. Eur J Biochem 201: 373-383, 1991.
9. Duverger N, Tremp G, Caillaud JM, Emmanuel F, Castro G, Fruchart JC, Steinmetz A, and Denèfle P. Protection against atherosclerosis in mice mediated by human apolipoprotein A-IV. Science 273: 966-968, 1996.
10. Fernández-Checa JC, Kaplowitz N, García-Ruiz C, Coleli A, Miranda M, Marí M, Ardite E, and Morales A. GSH transport in mitochondria: defense against TNF-induced oxidative stress and alcohol-induced defect. Am J Physiol Gastrointest Liver Physiol 273: G7-G17, 1997.
11. Ferretti G, Bacchetti T, Bicchiega V, and Curatola G. Effect of human Apo AIV against lipid peroxidation of very low density lipoproteins. Chem Phys Lipids 114: 45-54, 2002.
12. Fournier N, Atger V, Paul JL, Sturm M, Duverger N, Rothblat GH, and Moatti N. Human ApoA-IV overexpression in transgenic mice induces cAMP-stimulated cholesterol efflux from J774 macrophages to whole serum. Arterioscler Thromb Vasc Biol 20: 1283-1292, 2000.
13. Ghiselli G, Krishnan S, Beigel Y, and Gotto AM Jr. Plasma metabolism of apolipoprotein A-IV in humans. J Lipid Res 27: 813-827, 1986.
14. Goldberg DM and Spooner RJ. Glutathione reductase methods. Methods Enzymol 3: 258-264, 1983.
15. Hayashi H, Nutting DF, Fujimoto K, Cardelli JA, Black D, and Tso P. Transport of lipid and apolipoproteins A-I and A-IV in intestinal lymph of the rat. J Lipid Res 31: 1613-1625, 1990.
16. Kalogeris TJ, Fukagawa K, and Tso P. Synthesis and lymphatic transport of intestinal apolipoprotein A-IV in response to graded doses of triglyceride. J Lipid Res 35: 1141-1151, 1994.
17. Kalogeris TJ, Rodriguez MD, and Tso P. Control of synthesis and secretion of intestinal apolipoprotein A-IV by lipid. J Nutr 127, Suppl 3: 537S-543S, 1997.
18. Kletzien RF, Harris PKW, and Foellmi LA. Glucose-6-phosphate dehydrogenase: a "housekeeping" enzyme subject to tissue-specific regulation by hormones, nutrients, and oxidant stress. FASEB J 8: 174-181, 1994.
19. Lefevre M and Roheim PS. Metabolism of apolipoprotein A-IV. J Lipid Res 25: 1603-1610, 1984.
20. Leopold JA, Cap A, Scribner AW, Stanton RC, and Loscalzo J. Glucose-6-phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailability. FASEB J 15: 1771-1773, 2001.
21. Ostos MA, Conconi M, Vergnes L, Baroukh N, Ribalta J, Girona J, Caillaud JM, Ochoa A, and Zakin MM. Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-defi-cient mice. Arterioscler Thromb Vasc Biol 21: 1023-1028, 2001.
22. Pias EK and Aw TY. Early redox imbalance mediates hydroperoxide-induced apoptosis in mitotic competent undifferentiated PC-12 cells. Cell Death Differ 9: 1007-1016, 2002.
23. Pias EK and Aw TY. Apoptosis in mitotic competent undifferentiated cells is induced by cellular redox imbalance independent of reactive oxygen species production. FASEB J 16: 781-790, 2002.
24. Pias EK, Ekshyyan OY, Rhoads CA, Fuseler J, Harrison L, and Aw TY. Differential effects of superoxide dismutase isoform expression on hydroperoxide-induced apoptosis in PC-12 cells. J Biol Chem 278: 13294-13301, 2003.
25. Qin X, Swertfeger DK, Zheng S, Hui DY, and Tso P. Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation. Am J Physiol Heart Circ Physiol 274: H1836-H1840, 1998.
26. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809, 1993.
27. Swaney JB, Braithewaite F, and Eden HA. Characterization of the apolipoproteins of rat plasma lipoproteins. Biochemistry 16: 271-278, 1977.
28. Swezey RR and Epel D. Regulation of glucose-6-phosphate dehydrogenase activity in sea urchin eggs by reversible association with cell structural elements. J Cell Biol 103: 1509-1515, 1986.
29. Tian WN, Braunstein LD, Apse K, Pang J, Rose M, Tian X, and Stanton RC. Importance of glucose-6-phosphate dehydrogenase activity in cell death. Am J Physiol Cell Physiol 276: C1121-C1131, 1999.
30. Tian WN, Braunstein LD, Pang J, Stuhlmeier KM, Xi QC, Tian X, and Stanton RC. Importance of glucose-6-phosphate dehydrogenase activity for cell growth. J Biol Chem 273: 10609-10617, 1998.
31. Tian WN, Pignatore JN, and Stanton RC. Signal transduction proteins that associate with the platelet-derived growth factor (PDGF) receptor mediate the PDGF-induced release of glucose-6-phosphate dehydrogenase from permeabilized cells. J Biol Chem 269: 14798-14805, 1994.
32. Vowinkel T, Mori M, Krieglstein CF, Russell J, Saijo F, Bharwani S, Turnage RH, Davidson WS, Tso P, Granger DN, and Kalogeris TJ. Apolipoprotein A-IV inhibits experimental colitis. J Clin Invest 114: 260-269, 2004.
33. Weinberg RB and Scanu AM. Isolation and characterization of human apolipoprotein A-IV from lipoprotein-depleted serum. J Lipid Res 24: 52-59, 1983.
34. 2-associated C-apoproteins. J Lipid Res 26: 26-37, 1985.
35. Zhang Z, Apse K, Pang J, and Stanton RC. High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells. J Biol Chem 275: 40042-40047, 2000.